for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

RaySearch Laboratories AB (publ)

RAYb.ST

Latest Trade

164.20SEK

Change

0.70(+0.43%)

Volume

42,709

Today's Range

162.60

 - 

165.20

52 Week Range

82.35

 - 

193.00

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
163.50
Open
162.90
Volume
42,709
3M AVG Volume
1.65
Today's High
165.20
Today's Low
162.60
52 Week High
193.00
52 Week Low
82.35
Shares Out (MIL)
34.28
Market Cap (MIL)
4,184.10
Forward P/E
54.36
Dividend (Yield %)
--

Next Event

Q3 2019 RaySearch Laboratories AB (publ) Earnings Release

Latest Developments

More

RaySearch Q2 Operating Profit Rises To SEK 28.8 Mln

Raysearch And Mevion Extend Collaboration

RaySearch Laboratories Signs Multi-System Agreement With Swiss Medical Network

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About RaySearch Laboratories AB (publ)

RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Industry

Software & Programming

Contact Info

Sveavagen 44, Box 3297

+46.8.51053000

http://www.raysearchlabs.com

Executive Leadership

Lars Wollung

Independent Chairman of the Board

Johan Lof

Chief Executive Officer, President, Director

Bjorn Hardemark

Deputy Chief Executive Officer

Peter Thysell

Chief Financial Officer

Kjell Eriksson

Chief Science Officer

Key Stats

2.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, SEK)

2016

0.5K

2017

0.6K

2018

0.6K

2019(E)

0.8K
EPS (SEK)

2016

4.420

2017

3.430

2018

2.260

2019(E)

2.980
Price To Earnings (TTM)
65.16
Price To Sales (TTM)
5.71
Price To Book (MRQ)
8.00
Price To Cash Flow (TTM)
17.97
Total Debt To Equity (MRQ)
7.10
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
10.34
Return on Equity (TTM)
7.61

Latest News

BRIEF-RaySearch Laboratories Signs Multi-System Agreement With Swiss Medical Network

* SWISS MEDICAL NETWORK ADVANCES CANCER CARE IN SWITZERLAND WITH MULTI-SYSTEM AGREEMENT FOR ACCURAY RADIATION THERAPY SYSTEMS AND RAYSEARCH ONCOLOGY SOFTWARE SYSTEMS

BRIEF-RaySearch wins order from Mitchell Cancer Institute, USA

* MITCHELL CANCER INSTITUTE, US, SELECTS RAYSTATION FOR TOMOTHERAPY Source text for Eikon: Further company coverage: (Reporting By Stockholm newsroom)

BRIEF-Raysearch wins order in India

* RAYSTATION SELECTED FOR INDIA'S FIRST PROTON CENTER Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Raysearch say wins order in London

* RAYSTATION SELECTED FOR CHARING CROSS HOSPITAL AND HAMMERSMITH HOSPITAL IN LONDON Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

BRIEF-Raysearch wins order in Japan

* RAYSTATION SELECTED FOR NEW CARBON ION THERAPY CENTER IN JAPAN

BRIEF-RaySearch Q3 operating profit falls to SEK 1 mln​

* Q3 net sales SEK 111.7 M (125.7), of which revenues from RayStation SEK 99.1 M (112.6)

BRIEF-Raysearch enters agreement with Sumitomo for boron neutron capture therapy

* Raysearch enters agreement with Sumitomo for boron neutron capture therapy Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Raysearch enters BNCT field with Neutreon Therapeutics agreement

* Raysearch enters into the field of boron neutron capture therapy

BRIEF-RaySearch wins order in the USA

* RayStation selected for provision cares proton therapy center in Franklin, U.S. Source text for Eikon: Further company coverage:

BRIEF-Raysearch says received six orders in June

* Says eight additional proton therapy centers worldwide have chosen RayStation as their treatment planning system

BRIEF-Raysearch Q3 operating profit 38.5 mln SEK

* says within short we will sign additional long-term collaboration agreements with world-leading cancer clinics regarding raycare

BRIEF-Raysearch says chairman resigns after disagreement with CEO

* RaySearch's Chairman, Erik Hedlund, resigns from the Board with immediate effect following disagreement with the CEO

BRIEF-Raysearch says extends collaboration with Mevion

* Mevion and Raysearch extend collaboration to support raycare oncology information system and hyperscan adaptive aperture advanced impt capabilities Source text for Eikon: Further company coverage: (Stockholm Newsroom)

BRIEF-Raysearch says wins order for Raystation

* Says Queen Elizabeth Hospital Birmingham selects Raystation

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up